Previously, other studies showed similar effects in peripheral blood mononuclear cells obtained from women with preeclampsia after intervention with the use of silibinin including the inhibition of activation of the NF-κB-pathway and production of pro-inflammatory cytokines [80,95]. This evidence concerns the gene NFKB1 and preeclampsia.